loader
Please Wait
Applying Filters...
menu
    • menu

    Drug Product Composition: Cobicistat

    Client Email Product
    Menu

    Cobicistat

    ACTIVE PHARMA INGREDIENTS

    DEVELOPMENTS

    INTERMEDIATES

    FINISHED DOSAGE FORMULATIONS

    DRUG PRODUCT COMPOSITIONS

    RELATED EXCIPIENT COMPANIES

    EXCIPIENTS BY APPLICATIONS

    DIGITAL CONTENT

    GLOBAL SALES INFORMATION

    MARKET PLACE

    PATENTS & EXCLUSIVITIES

    PharmaCompass
    Xls

    Filters

    clear-filterReset all filters
    SearchXls

    USFDA APPLICATION NUMBER - 206353 / DOSAGE - TABLET;ORAL - EQ 300MG BASE;150MG

    Active Ingredient/Active Moiety
    Ingredient Name Basis of Strength Strength
    ATAZANAVIR SULFATE(UNII: 4MT4VIE29P)
    (ATAZANAVIR - UNII:QZU4H47A3S)     		ATAZANAVIR300mg
    COBICISTAT(UNII: LW2E03M5PG)
    (COBICISTAT - UNII:LW2E03M5PG)     		COBICISTAT150mg

    Inactive Ingredients

    Ingredient Name
    A-S Medication Solutions
    CELLULOSE, MICROCRYSTALLINE(OP1R32D61U)
    CROSCARMELLOSE SODIUM(M28OL1HH48)
    CROSPOVIDONE (15 MPA.S AT 5%)(68401960MK)
    CROSPOVIDONE(68401960MK)
    HYDROXYPROPYL CELLULOSE (1200000 MW)(RFW2ET671P)
    HYDROXYPROPYL CELLULOSE (TYPE H)(RFW2ET671P)
    MAGNESIUM STEARATE(70097M6I30)
    MICROCRYSTALLINE CELLULOSE(OP1R32D61U)
    SILICON DIOXIDE(ETJ7Z6XBU4)
    SODIUM STARCH GLYCOLATE TYPE A POTATO(5856J3G2A2)
    STEARIC ACID(4ELV7Z65AP)